Sector ratings Charles River Laboratories International, Inc.

Stocks

Market Closed - NYSE 21:00:03 17/08/2026 BST			5-day change	1st Jan Change
286.64 ^USD	+2.35%		+7.16%	+43.69%

08-13	Charles River Laboratories International Insider Sold Shares Worth $1,038,657, According to a Recent SEC Filing	MT
08-10	TD Cowen Adjusts PT on Charles River Laboratories International to $300 From $235, Maintains Buy Rating	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	13.37B		AA
LONZA GROUP AG	48.42B		AAA
REVOLUTION MEDICINES, INC.	43.66B	-	B	-	-
BEONE MEDICINES AG	39.51B		-
IQVIA HOLDINGS INC.	38.95B		AAA
CELLTRION, INC.	32.61B		A
ASCENDIS PHARMA A/S	16.32B	-	-	-	-
MEDPACE HOLDINGS, INC.	16.15B		BBB
EUROFINS SCIENTIFIC SE	14.16B		AA
ICON PUBLIC LIMITED COMPANY	12.59B		AAA
PHARMARON BEIJING CO., LTD.	12.12B		AA
BIO-TECHNE CORPORATION	11.28B		AA
ABIVAX	10.25B	-	BBB	-	-
PRAXIS PRECISION MEDICINES, INC.	10.24B	-	B	-	-
APOGEE THERAPEUTICS, INC.	10.15B	-	B	-	-
PROTAGONIST THERAPEUTICS, INC.	10.04B		BB		-
KYMERA THERAPEUTICS, INC.	9.76B	-	BBB	-	-
IONIS PHARMACEUTICALS, INC.	9.51B	-	A	-	-
TEMPUS AI, INC.	9.4B		A		-
QIAGEN N.V.	8.88B		AAA
Average	18.87B		A
Weighted average by Cap.			A